• About us
• Contact

Advertisement

Organisation › Details

Kurma Diagnostics Fund KDx Fund

Created in 2009, Kurma Partners is an European leading venture capital group specialized in Life Sciences and managing Kurma Biofund I, Kurma Biofund II and its accelerator fund, Kurma Diagnostics. The company has more than €250 million under management and develops an investment strategy supported by both the selection of the best investment opportunities in Europe and the development of a "proprietary" portfolio of companies in which Kurma steps in at creation stage. *

 

	Start	2015-06-04 existent
	Successor	Kurma Diagnostics 2 Fund (KDx2 Fund)
	Industry	Kurma Diagnostics Fund KDx Fund
	Industry 2	diagnostics (medical/biological)
	Region	Paris
	Country	France
	Street	5–7 rue de Monttessuy
	City	75340 Paris
	Tel	+33-1-5819-4407
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	50,000,000 (fund size at final closing (2015) 2015-01-01)
		* Document for »About Section«: DNA Script. (9/12/17). "Press Release: DNA Script Raises €11 Million ($13 Million) in Series A Financing Led by Illumina Ventures to Advance Development of Its DNA Synthesis Technology". Paris.
		Record changed: 2024-02-12

Advertisement

More documents for Eurazeo (Group)

• [1] Kurma Partners. (3/7/22). "Press Release: Kurma Partners Targets €250 Million for its First Growth Opportunities Fund". Paris....
• [2] PathoQuest SAS. (11/9/21). "Press Release: PathoQuest Closes up to €15 Million Series B Financing Round Led by Growth Investor SHS Capital". Paris & Tübingen....
• [3] Kaia Health Software GmbH. (4/28/21). "Press Release: Kaia Health Raises $75 Million Series C to Optimize MSK and COPD Care in the U.S. and Europe". New York, NY....
• [4] Synendos Therapeutics AG. (11/12/20). "Press Release: Synendos Therapeutics Raises CHF 20 Million in Series A Financing". Basel....
• [5] Kurma Partners. (11/9/20). "Press Release: Kurma Partners Strengthens Its Teams and Promotes Its Talents". Paris....
• [6] Corlieve Therapeutics SAS. (11/2/20). "Press Release: Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions". Paris....
• [7] Kurma Partners. (9/29/20). "Press Release: Kurma Partners Announces the First Closing of Kurma Diagnostics 2 (KDx2) Fund at €50 Million". Paris....
• [8] Kurma Partners. (4/29/20). "Press Release: Kurma Partners Announces the Final Closing of Its Kurma Biofund III Fund at €160 Million". Paris....
• [9] Kurma Partners. (1/21/19). "Press Release: Kurma Partners Sees Great Opportunities for Early-stage Biotech Investments in Germany and Launches Operations in Munich". Paris & Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.